| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Wexford Capital Lp | 10%+ Owner | $7.93M | Mar 13, 2024 | ||
| Arthur H. Amron | Director | $588K | Nov 10, 2025 | ||
| Oliver Spandow | Director | $552K | Nov 10, 2025 | ||
| Andrew Astor | President, CEO & CFO, Director | $204K | Mar 5, 2022 | ||
| Robert R. Banks Jr. | President and CEO, Director | $157K | May 14, 2024 | ||
| Alisa Lask | Director | $109K | Jan 1, 2025 | ||
| Tom Gwydir | Director | $95.2K | Jan 5, 2023 | ||
| Wesley S. Lobo | Chief Marketing Officer | $77.5K | Feb 16, 2022 | ||
| Lisa Nettis | Director | $63.1K | Nov 10, 2025 | ||
| Joseph M. Harris | Director | $39.7K | Jan 1, 2025 | ||
| Daron Evans | CEO Specialty Renal Products | $38.8K | May 24, 2021 | ||
| Judy Krandel | Chief Financial Officer | Mar 27, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|